Biotechnology: Biological Products (No Diagnostic Substances)

Board MeetingJul 30, 2026, 08:03 AM

Aligos Therapeutics Q2 2026 Earnings Call Scheduled for Aug 6

AI Summary

Aligos Therapeutics, Inc. announced that it will report its second quarter 2026 financial results on Thursday, August 6, 2026. The results will be released before the U.S. financial markets open.

Key Highlights

Aligos Therapeutics to report Q2 2026 financial results on Thursday, August 6, 2026.
Results will be released before the open of U.S. financial markets.

View SEC Filing

ALGS

Biotechnology: Biological Products (No Diagnostic Substances)

Aligos Therapeutics, Inc.

Price Impact